Cantitate/Preț
Produs

Targeting Treatment of Soft Tissue Sarcomas: Cancer Treatment and Research, cartea 120

Editat de J. Verweij, H.M. Pinedo
en Limba Engleză Paperback – 23 mar 2013
- Discusses the latest drug treatments in the field - Gleevec arranged a bulk sale for this title
- Written by leaders in the industry
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 33160 lei  38-45 zile
  Springer Us – 23 mar 2013 33160 lei  38-45 zile
Hardback (1) 33160 lei  38-45 zile
  Springer Us – 27 mai 2004 33160 lei  38-45 zile

Din seria Cancer Treatment and Research

Preț: 33160 lei

Preț vechi: 34905 lei
-5%

Puncte Express: 497

Preț estimativ în valută:
6353 6882$ 5448£

Carte tipărită la comandă

Livrare economică 06-13 mai

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781475779417
ISBN-10: 1475779410
Pagini: 196
Ilustrații: VII, 184 p.
Dimensiuni: 210 x 279 x 10 mm
Greutate: 0.45 kg
Ediția:Softcover reprint of the original 1st ed. 2004
Editura: Springer Us
Colecția Springer
Seria Cancer Treatment and Research

Locul publicării:New York, NY, United States

Public țintă

Research

Descriere

Recent achievements in the development of new techniques and agents for the treatment of cancer in general as well as for soft tissue sarcomas are tremendous. Molecular biology research has changed the landscape considerably and an increasing number of subtypes of soft tissue sarcomas are related to changes in cellular growth factors in the cell signaling pathways. This enables the development of targeted agents with specific activity against these factors. The presence of the KIT receptor at the surface of the gastrointestinal stroma tumor cell, and the activation constituted by mutations has led to the discovery of an extremely active specific KIT tyrosine kinase inhibitor.
In accordance with the more targeted approach in drug use, the changes in the field of radiation therapy and surgery basically focus on a better targeting of the disease, albeit not yet based on the molecular characteristics. All of these stress the importance of the multidisciplinary approach to the treatment of soft tissue sarcoma that was the focus of previous editions of this book.
Targeting Treatment of Soft Tissue Sarcomas summarizes the recent events in this field, putting the achievements in perspective. Physicians and researchers working in the field of soft tissue sarcomas must be aware of the changes in treatment, the underlying concepts, and of the changes we face in the future.

Cuprins

Targeted therapy: Ready for prime time?.- Volume-based radiotherapy targeting in soft tissue sarcoma.- Preoperative therapy for soft tissue sarcoma.- TNF-based isolated limb perfusion: A decade of experience with antivascular therapy in the management of locally advanced extremity soft tissue sarcomas.- Pitfalls in pathology of soft tissue sarcomas.- Molecular biology and cytogenetics of soft tissue sarcomas: Relevance for targeted therapies.- KIT and PDGF as targets.- Targeting mutant kinases in Gastrointestinal Stromal Tumors: A paradigm for molecular therapy of other sarcomas.- Targeting other abnormal signaling pathways in sarcoma: EGFR in synovial sarcomas, PPAR-? in liposarcomas.- Angiogenesis: a potential target for therapy of soft tissue sarcomas.

Recenzii

"The management of soft tissue sarcomas remains a difficult challenge. However, significant advances have occurred in our understanding of the important signaling molecules in these diseases. Experts in the field discuss the critical therapeutic targets and relevant treatment strategies for these malignancies."
(Steven T. Rosen, M.D., Series Editor)

Caracteristici

Summarizes the recent events in this field, putting the achievements in perspective.
Physicians and researchers working in the field of soft tissue sarcomas must be aware of the changes in treatment, the underlying concepts, and of the changes we face in the future